BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27606977)

  • 1. The emerging role of long non-coding RNAs in cutaneous melanoma.
    Leucci E; Coe EA; Marine JC; Vance KW
    Pigment Cell Melanoma Res; 2016 Nov; 29(6):619-626. PubMed ID: 27606977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNAs in cutaneous melanoma: clinical perspectives.
    Hulstaert E; Brochez L; Volders PJ; Vandesompele J; Mestdagh P
    Oncotarget; 2017 Jun; 8(26):43470-43480. PubMed ID: 28415644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Review on the Clinical Relevance of Long Non-Coding RNAs in Cutaneous Melanoma.
    De Falco V; Napolitano S; Esposito D; Guerrera LP; Ciardiello D; Formisano L; Troiani T
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.
    Aftab MN; Dinger ME; Perera RJ
    Arch Biochem Biophys; 2014 Dec; 563():60-70. PubMed ID: 25065585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between small and long non-coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces.
    Riefolo M; Porcellini E; Dika E; Broseghini E; Ferracin M
    Mol Oncol; 2019 Jan; 13(1):74-98. PubMed ID: 30499222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNAs in melanoma.
    Yu X; Zheng H; Tse G; Chan MT; Wu WK
    Cell Prolif; 2018 Aug; 51(4):e12457. PubMed ID: 29582492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
    Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
    J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNAs and melanoma: From diagnosis to therapy.
    Dashti F; Mirazimi SMA; Kazemioula G; Mohammadi M; Hosseini M; Razaghi Bahabadi Z; Mirazimi MS; Abadi MHJN; Shahini A; Afshari M; Mirzaei H
    Pathol Res Pract; 2023 Jan; 241():154232. PubMed ID: 36528985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA ILF3-AS1 promotes cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma.
    Chen X; Liu S; Zhao X; Ma X; Gao G; Yu L; Yan D; Dong H; Sun W
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process.
    Melixetian M; Pelicci PG; Lanfrancone L
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA and long-noncoding RNA signatures for improving the prognosis prediction of cutaneous skin melanoma efficiently.
    Zi SX; Xing YM; Wang CZ
    Eur Rev Med Pharmacol Sci; 2023 Jan; 27(1):66-73. PubMed ID: 36647851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: Regulation of the cancer epigenome by long non-coding RNAs.
    Forrest ME; Khalil AM
    Cancer Lett; 2017 Oct; 407():106-112. PubMed ID: 28400335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNAs in regulation of human breast cancer.
    Wang G; Liu C; Deng S; Zhao Q; Li T; Qiao S; Shen L; Zhang Y; Lü J; Meng L; Liang C; Yu Z
    Brief Funct Genomics; 2016 May; 15(3):222-6. PubMed ID: 26582840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNAs in prostate cancer: Biological and clinical implications.
    Das R; Feng FY; Selth LA
    Mol Cell Endocrinol; 2019 Jan; 480():142-152. PubMed ID: 30391670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
    Leibowitz-Amit R; Sidi Y; Avni D
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of microRNAs in melanoma.
    Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
    Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
    Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
    Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting long non-coding RNAs in cancers: progress and prospects.
    Li CH; Chen Y
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.